Close Menu

NEW YORK (GenomeWeb) – RainDance Technologies today pulled its planned initial public offering citing market conditions. 

In a document filed with the US Securities and Exchange Commission, the Billerica, Massachusetts-based digital PCR and targeted sequence enrichment firm said that it "has determined at this time not to proceed with the offering due to market conditions." It did not provide further details, but RainDance's decision follows a sharp sell-off in the public markets amid concerns about macroeconomic conditions. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

GenomeWeb reports that Veritas Genetics is suspending its US operations.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.